Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials

Overview of attention for article published in Frontiers in Neurology, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Readers on

mendeley: 8 Mendeley

Summary Blogs X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,732 followers.

New article: Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials https://t.co/JEkrf2qfut #MS #multiplesclerosis #neurology https://t.co/WEv0A66T

13 Oct 2022

Reply Repost Favourite

New Research: Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials: Background Multiple sclerosis (MS), an autoimmune disease, is… https://t.co/j

26 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.